A multicenter, double-blind, placebo-controlled study was conducted to evaluate the benefit and safety of long-term intravenous iron administration in patients with heart failure. For this purpose, 152 heart failure patients with iron deficiency received a daily intravenous iron supplement for one year. The treatment led to long-term improvements in the patients’ functional capacity (ability to cope with everyday tasks), symptoms, and quality of life. For more information, please read the study.
Ponikowski et al.